Patents by Inventor Sandeep B. Khandagale

Sandeep B. Khandagale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymorphs of a mPGES-1 inhibiting triazolone compound
    Patent number: 10457649
    Abstract: The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl)pivalamide (Compound of formula II), and process for preparation thereof.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: October 29, 2019
    Assignee: GLENMARK PHARMACEUTICALS S.A.
    Inventors: Nagarajan Muthukaman, Laxmikant A. Gharat, Suresh M. Kadam, Sachin Gavhane, Sandeep B. Khandagale, Sunil P. Nirgude
  • POLYMORPHS OF A mPGES-1 INHIBITING TRIAZOLONE COMPOUND
    Publication number: 20180370923
    Abstract: The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl) pivalamide (Compound of formula II), and process for preparation thereof.
    Type: Application
    Filed: August 31, 2018
    Publication date: December 27, 2018
    Inventors: Nagarajan Muthukaman, Laxmikant A. Gharat, Suresh M. Kadam, Sachin Gavhane, Sandeep B. Khandagale, Sunil P. Nirgude
  • Polymorphs of a mPGES-1 inhibiting triazolone compound
    Patent number: 10112914
    Abstract: The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl) pivalamide (Compound of formula II), and process for preparation thereof.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: October 30, 2018
    Assignee: GLENMARK PHARMACEUTICALS S.A.
    Inventors: Nagarajan Muthukaman, Laxmikant A. Gharat, Suresh M. Kadam, Sachin Gavhane, Sandeep B. Khandagale, Sunil P. Nirgude
  • POLYMORPHS OF A PGES-1 INHIBITING TRIAZOLONE COMPOUND
    Publication number: 20180134671
    Abstract: The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl) pivalamide (Compound of formula II), and process for preparation thereof.
    Type: Application
    Filed: June 13, 2016
    Publication date: May 17, 2018
    Inventors: Nagarajan Muthukaman, Laxmikant A. Gharat, Suresh M. Kadam, Sachin Gavhane, Sandeep B. Khandagale, Sunil P. Nirgude